Mitochondrial DNA haplogroups and risk of transient ischaemic attack and ischaemic stroke: a genetic association study

The Lancet Neurology

Volumn 9, Issue 5, 2010, Pages 498-503

  Chinnery, Patrick F ^a   Elliott, Hannah R ^a   Syed, Anila ^b   Rothwell, Peter M ^b  

^a NEWCASTLE UNIVERSITY   (United Kingdom)

^b JOHN RADCLIFFE HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

MITOCHONDRIAL DNA;

ARTICLE; CEREBROVASCULAR ACCIDENT; CONTROLLED STUDY; GENETIC ASSOCIATION; GENETIC VARIABILITY; HAPLOTYPE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RISK FACTOR; TRANSIENT ISCHEMIC ATTACK;

CASE-CONTROL STUDIES; DNA, MITOCHONDRIAL; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; GENETICS, POPULATION; HAPLOTYPES; HUMANS; INCIDENCE; ISCHEMIC ATTACK, TRANSIENT; PATIENT SELECTION; REGRESSION ANALYSIS; RISK; RISK FACTORS; STROKE; TIME FACTORS;

EID: 77950662782     PISSN: 14744422     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1474-4422(10)70083-1     Document Type: Article

References (36)

1. Jamrozik K., Broadhurst R.J., Anderson C.S., and Stewart-Wynne E.G. The role of lifestyle factors in the etiology of stroke. A population-based case-control study in Perth, Western Australia. Stroke 25 (1994) 51-59
2. Flossmann E., Schulz U.G., and Rothwell P.M. Systematic review of methods and results of studies of the genetic epidemiology of ischemic stroke. Stroke 35 (2004) 212-227
3. Flossmann E., and Rothwell P.M. Family history of stroke does not predict risk of stroke after transient ischemic attack. Stroke 37 (2006) 544-546
4. Touze E., and Rothwell P.M. Sex differences in heritability of ischemic stroke: a systematic review and meta-analysis. Stroke 39 (2008) 16-23
5. Matarin M., Brown W.M., Singleton A., Hardy J.A., and Meschia J.F. Whole genome analyses suggest ischemic stroke and heart disease share an association with polymorphisms on chromosome 9p21. Stroke 39 (2008) 1586-1589
6. Gretarsdottir S., Thorleifsson G., Manolescu A., et al. Risk variants for atrial fibrillation on chromosome 4q25 associate with ischemic stroke. Ann Neurol 64 (2008) 402-409
7. Ikram M.A., Seshadri S., Bis J.C., et al. Genomewide association studies of stroke. N Engl J Med 360 (2009) 1718-1728
8. Hirano M., Ricci E., Koenigsberger M.R., et al. Melas: an original case and clinical criteria for diagnosis. Neuromuscul Disord 2 (1992) 125-135
9. Zhu H.Y., Wang S.W., Martin L.J., et al. The role of mitochondrial genome in essential hypertension in a Chinese Han population. Eur J Hum Genet 17 (2009) 1501-1506
10. Fuku N., Park K.S., Yamada Y., et al. Mitochondrial haplogroup N9a confers resistance against type 2 diabetes in Asians. Am J Hum Genet 80 (2007) 407-415
11. Dahmani Y., Marcuello A., Diez-Sanchez C., Ruiz-Pesini E., Montoya J., and Lopez-Perez M.J. Association of human mitochondrial DNA variants with plasma LDL levels. Mitochondrion 8 (2008) 247-253
12. Guo L.J., Oshida Y., Fuku N., et al. Mitochondrial genome polymorphisms associated with type-2 diabetes or obesity. Mitochondrion 5 (2005) 15-33
13. Tanaka M., Fuku N., Nishigaki Y., et al. Women with mitochondrial haplogroup N9a are protected against metabolic syndrome. Diabetes 56 (2007) 518-521
14. Pello R., Martin M.A., Carelli V., et al. Mitochondrial DNA background modulates the assembly kinetics of OXPHOS complexes in a cellular model of mitochondrial disease. Hum Mol Genet 17 (2008) 4001-4011
15. Moreno-Loshuertos R., Acin-Perez R., Fernandez-Silva P., et al. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet 38 (2006) 1261-1268
16. Rosa A., Fonseca B.V., Krug T., et al. Mitochondrial haplogroup H1 is protective for ischemic stroke in Portuguese patients. BMC Med Genet 9 (2008) 57
17. Nishigaki Y., Yamada Y., Fuku N., et al. Mitochondrial haplogroup A is a genetic risk factor for atherothrombotic cerebral infarction in Japanese females. Mitochondrion 7 (2007) 72-79
18. Finnila S., Hassinen I.E., and Majamaa K. Phylogenetic analysis of mitochondrial DNA in patients with an occipital stroke. Evaluation of mutations by using sequence data on the entire coding region. Mutat Res 458 (2001) 31-39
19. Rothwell P.M., Coull A.J., Silver L.E., et al. Population-based study of event-rate, incidence, case fatality, and mortality for all acute vascular events in all arterial territories (Oxford Vascular Study). Lancet 366 (2005) 1773-1783
20. Coull A.J., and Rothwell P.M. Underestimation of the early risk of recurrent stroke: evidence of the need for a standard definition. Stroke 35 (2004) 1925-1929
21. Luepker R.V., Apple F.S., Christenson R.H., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108 (2003) 2543-2549
22. Elliott H.R., Samuels D.C., Eden J.A., Relton C.L., and Chinnery P.F. Pathogenic mtDNA mutations are common in the general population. Am J Hum Genet 80 (2008) 254-260
23. Baudouin S.V., Saunders D., Tiangyou W., et al. Mitochondrial DNA and survival after sepsis: a prospective study. Lancet 366 (2005) 2118-2121
24. Chinnery P.F., Mowbray C., Patel S.K., et al. Mitochondrial DNA haplogroups and type 2 diabetes: a study of 897 cases and 1010 controls. J Med Genet 44 (2007) e80
25. Chinnery P.F., Mowbray C., Elliot H., et al. Mitochondrial DNA haplogroups and amyotrophic lateral sclerosis. Neurogenetics 8 (2007) 65-67
26. Lewington S., Clarke R., Qizilbash N., Peto R., and Collins R. Age-specific relevance of usual BP to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360 (2002) 1903-1913
27. Armitage P., Berry G., and Matthews J.N.S. Statistical Methods in Medical Research. 4th edn. (2002), Blackwell, Oxford
28. Saxena R., de Bakker P.I., Singer K., et al. Comprehensive association testing of common mitochondrial DNA variation in metabolic disease. Am J Hum Genet 79 (2006) 54-61
29. Benn M., Schwartz M., Nordestgaard B.G., and Tybjaerg-Hansen A. Mitochondrial haplogroups: ischemic cardiovascular disease, other diseases, mortality, and longevity in the general population. Circulation 117 (2008) 2492-2501
30. Pyle A., Foltynie T., Tiangyou W., et al. Mitochondrial DNA haplogroup cluster UKJT reduces the risk of PD. Ann Neurol 57 (2005) 564-567
31. Ghezzi D., Marelli C., Achilli A., et al. Mitochondrial DNA haplogroup K is associated with a lower risk of Parkinson's disease in Italians. Eur J Hum Genet 13 (2005) 748-752
32. van der Walt J.M., Dementieva Y.A., Martin E.R., et al. Analysis of European mitochondrial haplogroups with Alzheimer disease risk. Neurosci Lett 365 (2004) 28-32
33. Moreno-Loshuertos R., Acin-Perez R., Fernandez-Silva P., et al. Differences in reactive oxygen species production explain the phenotypes associated with common mouse mitochondrial DNA variants. Nat Genet 38 (2006) 1261-1268
34. Carelli V., Ross-Cisneros F.N., and Sadun A.A. Mitochondrial dysfunction as a cause of optic neuropathies. Prog Retin Eye Res 23 (2004) 53-89
35. Schleicher E., and Friess U. Oxidative stress, AGE, and atherosclerosis. Kidney Int Suppl 106 (2007) S17-S26
36. Schleicher M., Shepherd B.R., Suarez Y., et al. Prohibitin-1 maintains the angiogenic capacity of endothelial cells by regulating mitochondrial function and senescence. J Cell Biol 180 (2008) 101-112